The Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology have released new guidelines and recommendations for neurologists caring for multiple sclerosis patients.
Multiple sclerosis (MS) is an autoimmune disease in which your own immune system attacks the nerves in the brain and spinal cord. This can lead to various symptoms all over the body including difficulties walking, talking, swallowing and thinking.
Vitamin D likely plays a role in multiple sclerosis. Past research has shown that those with low vitamin D levels are most likely to develop MS later in life. Researchers have also found that MS is more prevalent in places farther from the equator, where there is much less UVB, the spectrum that helps you make vitamin D.
The Scientific Department of Neuroimmunology (DCNI) of the Brazilian Academy of Neurology (ABN) met in September of 2013 to review the latest research in vitamin D and MS and help establish a set of guidelines on vitamin D for neurologists who care for people with MS.
Here are their recommendations and guidelines:
- Vitamin D shouldn’t be used as a sole treatment for MS. However, it can and should be used in conjunction with traditional medications.
- Vitamin D should be given to patients with MS regardless of the stage of disease.
- Vitamin D levels lower than 30 ng/ml should be corrected at any stage of MS.
- Patients should be prescribed their own vitamin D regimen based on their individual needs to reach vitamin D levels between 40 ng/ml and 100 ng/ml.
- Vitamin D levels should be determined and corrected in those with first signs of MS to help prevent conversion to MS.
Brum, D. G. et al. Supplementation and therapeutic use of vitamin Di n patients with multiple sclerosis: Consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology. Arquivos de Neuro-Psiquiatria, 2014.